Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / 抗有糸分裂エージェント…
JoVE Journal
Cancer Research

This content is Open Access.

JoVE Journal Cancer Research
抗有糸分裂エージェント ドセタキセルに対する抵抗性の前立腺癌細胞モデルの生成
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Journal (Cancer Research)
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy
Journal (Cancer Research)
Longitudinal Intravital Imaging of Brain Tumor Cell Behavior in Response to an Invasive Surgical Biopsy
 
Click here for the English version

抗有糸分裂エージェント ドセタキセルに対する抵抗性の前立腺癌細胞モデルの生成

Article DOI: 10.3791/56327-v • 06:44 min • September 8th, 2017
September 8th, 2017 •
1, 1, 1, 1, 1, 1,2
1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

がん治療への抵抗は、病気の進行と死亡に貢献します。抵抗性のメカニズムの基盤を決定する治療応答の改善に不可欠です。この原稿の詳細 PC 患者におけるドセタキセル抵抗への進行に関与する経路を解剖するため (PC) 前立腺癌のタキサン耐性細胞モデルを生成するプロトコル。

Tags

がん研究、問題 127、前立腺癌 (PC)、化学療法抵抗性、抗有糸分裂剤、タキサン系薬剤、ドセタキセル、微小管をターゲットにエージェント
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter